Strychnine-sensitive glycine receptors mediate inhibitory neurotransmission occurring in the brain stem and spinal cord. Alcohols, volatile anesthetics and inhaled drugs of abuse are positive allosteric modulators of glycine receptor function, normally enhancing function only in the presence of glycine. A complication in studying allosteric actions on ligand-gated ion channels is in the dissection of their effects on neurotransmitter binding from their effects on channel opening. Mutation of an aspartate residue at position 97 to arginine in the glycine receptor a1 subunit simulated the effects of glycine binding, producing receptors that exhibited tonic channel opening in the absence of neurotransmitter; i.e. these receptors demonstrated a dissociation of channel opening from neurotransmitter binding. In these receptors, ethanol, enflurane, chloroform, halothane, 1,1,1-trichloroethane and toluene elicited inward currents in the absence of glycine. We previously identified mutations on ligand-gated ion channels that eliminate ethanol, anesthetic and inhalant actions (such as S267I on a1 glycine receptors). The double mutant (D97R and S267I) receptors were both constitutively active and resistant to the enhancing effects of ethanol and enflurane. These data demonstrate that ethanol and volatile anesthetics can affect glycine receptor channel opening independently of their effects on enhancing neurotransmitter binding.
Glycine receptors (Gly-Rs) are members of the nicotinic acetylcholine receptor (nACh-R) superfamily of pentameric ligand-gated ion channels (LGICs) that also includes the GABA types A and C, and serotonin type 3 (5HT3) receptors (Ortells and Lunt 1995) . These receptors contribute to fast synaptic signaling, allowing for rapid changes in neuronal excitability. The anion-conducting strychnine-sensitive Gly-R channels are responsible for the majority of inhibitory neurotransmission that occurs in the brain stem and spinal cord. Thus far, four a and a single b subunit of the Gly-R have been identified (Legendre 2001) . Although a2 homomeric receptors predominate during development, they are replaced shortly after birth by heteromeric Gly-Rs thought to be comprised of three a1 and two b subunits (Legendre 2001) . The a1 subunit also expresses homomerically and, in recombinant systems, these receptors possess most of the pharmacological properties of native receptors. Both homomeric a1 and native Gly-Rs are sensitive to positive allosteric modulation by n-alcohols, volatile anesthetics, inhalants and propofol (Belelli et al. 1999; Mihic 1999; Beckstead et al. 2000) .
The binding of agonists favors conformational states of the oligomeric LGIC protein in which the integral ion channel is open. The agonist is thought to have a higher binding affinity for the conformational state of the receptor that is associated with an open channel (Galzi et al. 1996; Chang and Weiss 1999b; Grosman and Auerbach 2001) . Channel opening events in the absence of neurotransmitter binding are usually rare occurrences in wild-type receptors (Jackson 1989; Birnir et al. 2001) . Mutations of specific amino acids of subunits comprising the nACh-R superfamily result in receptors that display spontaneous openings in the absence of ligand; i.e constitutive activity (Auerbach et al. 1996; Weiss 1998, 1999a; Corringer et al. 1999; Auerbach 2000, 2001; Findlay et al. 2001; Mihic et al. 1997; Pan et al. 1997 ; Thompson et al. 1999) . These mutations thus increase the probability that the oligomeric complex will adopt an open channel conformation without the prior need for neurotransmitter binding.
Allosteric modulators of LGIC function are usually without effect when applied alone, enhancing or inhibiting currents only in the presence of neurotransmitter. Benzodiazepine receptor agonists, for example, increase the frequency of GABA-evoked GABA A receptor mediated channel opening events while barbiturates increase the duration of openings Twyman et al. 1989) . This has led to the hypothesis that positive allosteric modulators affect channel opening events through agonist-dependent mechanisms by increasing the on rate or slowing the off rate of the neurotransmitter (Ticku 1980; Rogers et al. 1994; Li and Pearce 2000) . Since neurotransmitter binding and channel opening are interdependent processes whose parameters depend upon one another, experimental dissection of the two has been impossible (Colquhoun 1998) . We recently discovered that the mutation of aspartic acid residue 97 in the N-terminal extracellular region of the glycine a1 subunit to arginine (D97R) produced receptors that demonstrate constitutive activity. This mutant Gly-R allowed us to test for the first time the hypothesis that allosteric modulators of glycine receptors have effects on channel opening independent of their effects on neurotransmitter binding.
Materials and methods

Materials
Penicillin, streptomycin, gentamycin, 3-aminobenzoic acid ethyl ester, GABA, glycine, collagenase, enflurane, chloroform, ethanol (EtOH), toluene, halothane and 1,1,1-trichloroethane (TCE) were purchased from Sigma (St Louis, MO, USA). All other chemicals used were of reagent grade. Xenopus laevis were obtained from Xenopus Express (Homosassa, FL, USA).
Oocyte isolation and cDNA nuclear injection
The oocyte isolation and storage, site-directed mutagenesis, and cDNA injection procedures were performed as described previously (Beckstead et al. 2000 (Beckstead et al. , 2002 . Oocytes were injected with cDNAs (1.5 ng/30 nL) of wild-type or mutated human Gly-R a1 subunits subcloned into either the pCIS2 or the pBKCMV vector; the latter had been modified by removal of the lac promoter and the lacZ ATG (Mihic et al. 1997) . Oocytes usually expressed receptors in one to two days, and electrophysiological measurements were made 1-7 days after cDNA injection.
Oocyte electrophysiological recording Animal poles of oocytes were impaled with two high-resistance (0.5-10 MW) glass electrodes filled with 3 M KCl. Oocytes were voltage-clamped at ) 70 mV using a Warner Instruments OC-725C oocyte clamp (Hamden, CT, USA). A large inward current observed in D97R receptors subsequent to voltage clamping was allowed to reach equilibrium (usually 10-30 min) before drug effects were determined. Drugs were applied to oocytes for either 30 or 60 s. In experiments testing for allosteric modulation of the effects of glycine, the modulator was applied for 30 or 60 s (until the direct activation had reached a plateau) before application of the modulator + glycine solution for an additional 30 s. Washout periods (5-18 min) were allowed to ensure complete recovery of receptors from desensitization between drug applications. Oocytes were perfused with modified Barth's saline (MBS, Beckstead et al. 2000) buffer (with or without drug) at a rate of 2 mL/min using a Masterflex USA peristalsis pump (Cole Parmer Instrument Co., Vernon Hills, IL, USA) that connected drug-containing vials to the perfusion chamber through 18-gauge polyethylene tubing. Changes in the clamping current were recorded on a strip-chart recorder (Cole Parmer Co.) and the peak currents were measured and used in data analysis. Oocyte bath concentrations of modulators were determined by gas chromatography as described previously by Eger et al. (1999) .
Molecular modeling
The crystal structure of the acetylcholine binding protein (Brejc et al. 2001) was obtained from the Protein Data Bank (1I9B). This protein has high homology with the extracellular ligand-binding domain of the superfamily of ligand gated ion channels. We used Clustal W (Thompson et al. 1997) to align the amino acid sequence of the acetylcholine binding protein with that of the glycine a1 receptor. Corresponding residues in the crystal structure of 1I9B were replaced with those in the a1 Gly-R sequence using the Biopolymer module of Insight 2000 (MSI, San Diego, CA, USA). The resulting pentameric protein was rendered as a ribbon structure. The amino acid residues that surround the ligand-binding pocket were rendered with space-filling surfaces that were colored to show the most positive (blue) and most negative (red) electrostatic potentials. The mutated residue D97R is shown in yellow near the edge of the ligand binding pocket, at the interface with the adjacent subunit, and over 30 Å from the second mutated residue S267I (not shown).
Statistics
All groups of data were collected using oocytes obtained from at least two different frogs. Statistics were performed on data obtained from oocytes by t-tests or two-way analyses of variance (ANOVA), as indicated. Hill coefficients were determined by fitting the glycine concentration-response curves to the following equation:
where I is the current peak height elicited by a given concentration of glycine [A], I max is the peak produced by a maximally effective concentration of glycine, EC 50 is the concentration of glycine that produces a half-maximal activation and n H is the Hill slope.
Results
Voltage clamping of oocytes that expressed D97R a1 Gly-Rs elicited a large inward current that decreased to a plateau after several minutes, after which experiments were initiated. The glycine binding site competitive antagonist strychnine (1 mM) and the non-competitive antagonist picrotoxin (1 mM) produced outward currents in the absence of glycine, indicative of the antagonism of spontaneous opening events ( Fig. 1 ). In contrast, in wild-type Gly-R these compounds have no effects in the absence of glycine. The D97R a1 GlyRs retained sensitivity to glycine, suggesting that a subpopulation of channels exists in a closed state, or possibly that channels are already open in a subconductance state before the application of glycine ( Fig. 1 ). In addition to being gated by glycine, D97R Gly-R were also directly activated by EtOH and the volatile anesthetics enflurane and chloroform in a concentration-dependent manner (Fig. 2) . The anesthetics and alcohol produced no currents when tested in the presence of either strychnine or picrotoxin. The mutation of Gly-R a1 Ser267 to isoleucine (S267I) eliminated EtOH enhancement of Gly-R function while other mutations at that site also decreased the magnitude of enhancement produced by volatile anesthetics (Mihic et al. 1997) . To better characterize the actions of EtOH and volatile anesthetics on D97R a1 Gly-Rs, we next expressed a1 Gly-Rs possessing both the D97R and the S267I mutations. EtOH (25-200 mM) differentially affected D97R and the D97R-S267I receptors, acting in a concentration-dependent manner as an agonist and an inverse agonist, respectively (Fig. 3a) . The same was true for the volatile anesthetics enflurane ( Fig. 3b) and halothane, as well as the inhaled solvent TCE (Fig. 3c) . However, the effect of chloroform and the inhalant toluene on D97R spontaneous channel opening was unaffected by the S267I mutation (Fig. 3d) .
Glycine concentration-response curves were generated for wild-type, D97R and D97R-S267I Gly-Rs. Both the D97R and D97R-S267I Gly-Rs exhibited shallow, left-shifted concentration-response curves compared with wild-type Gly-Rs (Fig. 4) . Glycine EC 50 s for the fitted curves were 246 lM for D97R, 248 lM for D97R-S267I, and 467 lM for wild-type a1 Gly-Rs. Hill slopes were 0.61, 0.61 and 1.44, respectively.
EtOH is a positive allosteric modulator on wild-type Gly-R channel function, producing effects only in the presence of neurotransmitter. To determine if EtOH modulates neurotransmitter-activated D97R receptor function, we next constructed glycine concentration-response curves in the presence and absence of 200 mM EtOH (Fig. 5a ). Unlike its effects on wild-type receptors, EtOH had no enhancing effect on D97R a1 Gly-R activation by glycine. This lack of effect was also seen using enflurane and chloroform, both of which failed to enhance currents produced by a low concentration (10 lM) of glycine (Fig. 5b) .
Discussion
In wild-type LGICs, the experimental dissociation of neurotransmitter binding from the consequences of that binding (i.e. channel opening) has proven difficult. Within microseconds, neurotransmitter binding results in the opening of the intrinsic channel pore (Parzefall et al. 1998) . The opening of the channel pore, in turn, increases the affinity of neurotransmitter for its binding site (Chang and Weiss 1999b) . These two processes (defined pharmacologically as efficacy and affinity) are causally linked, and any drug that may only affect one would appear to have effects on both (Colquhoun 1998; Zhou et al. 1998; Maksay et al. 2000) . Our demonstration of the direct activating effects by volatile anesthetics and ethanol in the absence of neurotransmitter on the D97R a1 Gly-R suggests that these modulators of a1 Gly-R function can have effects specifically on channel opening. Our results do not preclude the possibility that alcohols and volatile anesthetics affect neurotransmitter affinity (Zhou et al. 1998; Li and Pearce 2000; Narahashi 2000) ; they simply suggest that actions on channel opening may be occurring as well. Single-channel studies have demonstrated multiple effects of ethanol and halothane on LGIC opening kinetics (Yeh et al. 1991; Tatebayashi et al. 1998) , including increases in mean open time and frequency of openings. Even with these detailed findings, it has previously been impossible to experimentally remove modulator effects on ligand binding from effects on channel opening, a confound addressed in this investigation.
Previous work has demonstrated that point mutations can produce constitutively active GABA A (Mihic et al. 1997; Chang and Weiss 1999a; Thompson et al. 1999; Findlay et al. 2001) , GABA C (Pan et al. 1997; Chang and Weiss 1998) , nACh (Auerbach et al. 1996; Corringer et al. 1999; Auerbach 2000, 2001) and glycine (Mihic et al. 1997) receptors. Each of these engineered mutations is located in the second and third transmembrane segments (TM2 and TM3). TM2 lines the ion channel pore (Xu and Akabas 1996) , suggesting that alterations in channel structure are enhancing gating, thus resulting in spontaneous opening. TM2 and TM3 also contain residues thought to constitute part of the alcohol/anesthetic/inhalant binding pocket on these receptors (Wick et al. 1998; Mascia et al. 2000; Beckstead et al. 2001) . That overlapping regions of these Fig. 3 The S267I mutation alters the ability of ethanol and some volatile anesthetics to activate D97R a1 Gly-R. The S267I mutation decreases or eliminates the allosteric modulation of most alcohols and anesthetics, but not chloroform, on wild-type a1 Gly-Rs. We tested whether this would also be true for the direct activation of D97R mutant Gly-Rs. Oocytes expressing D97R and doubly mutated D97R-S267I Gly-Rs displayed differential sensitivity to 25-200 mM EtOH (a, receptors are responsible for both spontaneous channel opening and alcohol/anesthetic actions considerably limits the utility of these receptors for the study of these drugs. Thus, none of the tonically active receptors studied previously has been suitable for testing the hypothesis that ethanol and volatile anesthetics have direct effects on channel opening. The D97R mutation, because it is an N-terminal extracellular domain substitution, produces a constitutively active receptor that does not have this shortcoming. The strength of the present model for studying modulators is that it produces tonic activity while preserving a wild-type channel pore region (Xu and Akabas 1996) and a wild-type alcohol/anesthetic binding pocket (Wick et al. 1998; Mascia et al. 2000) .
Although benzodiazepines and barbiturates are generally considered positive allosteric modulators of GABA-evoked GABA A receptor-mediated currents, there have been reports that these compounds are capable of activating GABA A receptors in the absence of neurotransmitter (Steinbach and Akk 2001; Walters et al. 2000) . This direct activation is generally seen only at drug concentrations substantially greater than those required for modulation of GABAmediated currents, suggesting distinct mechanisms likely evoked by different binding sites (Dalziel et al. 1999; Neelands et al. 1999; Walters et al. 2000; Steinbach and Akk 2001) . Ethanol, anesthetics and inhalants are positive allosteric modulators of GABA A and glycine receptor function (Beckstead et al. 2000; Belelli et al. 1999; Mihic 1999) , but produce no direct receptor activation in the absence of neurotransmitter at drug concentrations approximately those seen in vivo. The direct activating effects observed in this investigation occur at drug concentrations similar to those seen in previous studies investigating the modulatory effects of these drugs on glycine-evoked currents. This suggests that these compounds are having a direct effect on channel opening through the same mechanism as their modulatory effects on wild-type receptors. Given the apparent multiple mechanisms of action of ethanol and anesthetics on ligand-gated ion channel kinetics (Tatebayashi et al. 1998) , mechanistic investigations of this kind are novel contributions to our understanding of these drugs.
The addition of the second mutation (S267I), that decreases or eliminates the modulatory effects of EtOH and enflurane on wild-type receptors (Mihic et al. 1997) , changes some D97R receptor agonists into inverse agonists. This suggests that the D97R mutation did not create a new alcohol/anesthetic binding site capable of facilitating direct activation of the receptor. Rather, the same alcohol/ anesthetic/inhalant binding site as found on wild-type receptors between TM2 and TM3 appears to be responsible, one whose intrinsic efficacy is largely determined by the Fig. 4 Effects of the D97R mutation on glycine sensitivity. Glycine concentration-response curves generated using D97R and D97R-S267I a1 Gly-R demonstrated shallow, concentration-dependent responses to agonist. Tonic currents (typically 30-60% of the current elicited by a maximally effective concentration of glycine) were subtracted from currents observed in the presence of glycine in the D97R mutants. When normalized to maximal current and compared with wild-type receptors, mutant Gly-Rs exhibit left-shifted responses; the glycine EC 50 s for D97R, D97R-S267I and wild-type a1 Gly-R were 246, 248 and 467 lM, respectively. The Hill coefficients were 0.61 for D97R and D97R-S267I a1 Gly-R and 1.44 for wild-type receptors. Data are expressed as mean ± SEM of four oocytes. residue at position 267. This conclusion is further strengthened by the similar effects of chloroform on both D97R and D97R-S267I receptors; the S267I mutation also minimally affects chloroform enhancement of wild-type Gly-R function.
Although less likely, it should be mentioned that the anesthetics may have an effect on the ligand-binding region as well, producing a response that can then be modified indirectly by mutations at S267. Despite the dissociation of binding and gating, strychnine and glycine sensitivity suggests that binding site alterations can still affect channel gating in the D97R Gly-R. The efficacy of a compound acting on a ligand-gated ion channel depends on both the compound and the receptor. A drug may be classified as an agonist, antagonist or inverse agonist, depending on whether its efficacy is positive, zero or negative, respectively. Modulation of receptor function can be altered by either changing the structure of the compound or by changing a relevant portion of the receptor. For example, mutations at residue 142 on the GABA A receptor c2 subunit result in benzodiazepine receptor antagonists and inverse agonists functioning as partial agonists (Mihic et al. 1994) . Similarly, mutations of a1 Gly-R S267 to isoleucine (S267I) or tyrosine (S267Y) produce receptors that are insensitive to EtOH and enflurane, respectively (Mihic et al. 1997) . However, the S267I mutation (and its GABA A receptor equivalent) has virtually no effect on chloroform actions at glycine and GABA A receptors (Beckstead et al. 2001; Jenkins et al. 2001) . Despite these findings, chloroform is generally thought to act at the same binding site as ethanol and enflurane on these receptors, bordered by Ser267 and the conserved equivalent in a1 glycine and GABA A receptors. The serine to isoleucine mutation is not drastic enough to eliminate chloroform action, but larger amino acid substitutions at S267 have prevented chloroform action in Gly-Rs (unpublished observations), while substitutions within TM2 and TM3 have prevented chloroform enhancement in GABA A receptors (Jenkins et al. 2001) .
Exactly why the D97R mutation results in channels that open spontaneously is not clear. Residue 97 has itself not been implicated in the binding of neurotransmitter to the a1 Gly-R. It is, however, in close proximity to several residues (I93, A101, N102) thought to constitute part of the glycine binding site (Vafa et al. 1999) . Based on work with the nACh-R, the neurotransmitter binding site is believed to reside in the N-terminal extracellular region of the protein, at the interface between two subunits about 30 Å from the membrane (Unwin 1993; Brejc et al. 2001) . Mutagenesis studies have suggested a binding site made up of six binding loops (Corringer et al. 2000) and many residues have been identified that constitute the agonist binding site in the glycine (Rajendra et al. 1995) and GABA A (Boileau et al. 1999; Wagner and Czajkowski 2001) receptors. Other mutagenesis studies have identified the extracellular loop between TM2 and TM3 (Lynch et al. 1997; Davies et al. 2001) as well as the TM3 itself (Wang et al. 1999) to be important in channel gating but not agonist binding. Brejc et al. (2001) recently reported the crystal structure of an acetylcholine binding protein with significant amino acid sequence homology to the nACh-R N-terminal extracellular domain. If this structure is also similar to other members of the nACh-R superfamily of ligand-gated ion channels, such as the Gly-R, then D97 would be located immediately adjacent to, but not in, the ligand binding region (Fig. 6) . We used the coordinates of the acetylcholine binding protein to build a model of the extracellular domain of a glycine a1 receptor. This model shows that the mutated residue D97R is adjacent to the ligand-binding pocket but is approximately 30 Å distant from serine 267 in TM2. By making a subtle change near this neurotransmitter site, the D97R mutation may be simulating the binding of neurotransmitter, causing the receptor to exist in a bound conformation despite the absence of neurotransmitter. Alternately, the mutation may alter the resting (closed) state of the receptor such that the quaternary structure of the protein more closely resembles the transition state between closed and open conformations (Changeux and Edelstein 1998 (Colquhoun 1998) . Second, drugs that normally act only as positive allosteric modulators of neurotransmitter-evoked wild-type receptor function can act as agonists on the mutated receptors; this is described as an ÔL-phenotypeÕ by Galzi et al. (1996) . Third, the agonist concentration-response curve is shifted to the left, an increase in apparent affinity that could instead be explained as an increase in efficacy (Colquhoun 1998) . Each of these observations suggests that the D97R mutation produces its effects by changing the thermodynamic equilibrium to favor open-channel conformational states. In contrast to the other drugs tested, the Gly-R competitive antagonist strychnine and the non-competitive antagonist picrotoxin effected channel closing events in D97R receptors. Similar results have been observed with the GABA A receptor competitive antagonist bicuculline, which inhibits constitutively active GABA A receptors; this has led some to suggest reclassifying bicuculline as an Ôallosteric inhibitorÕ (Ueno et al. 1997; Chang and Weiss 1999a; Thompson et al. 1999; Birnir et al. 2001) . The most likely explanation for this phenomenon is that strychnine binds with greater affinity to the closed state, stabilizing the spontaneously cycling D97R Gly-R channel in its closed conformation.
The reason that the D97R mutation eliminates alcohol and anesthetic modulation of glycine-mediated responses (seen so clearly in wild-type receptors) is not immediately evident. One possibility is that wild-type Gly-R channel opening requires the binding of multiple molecules of neurotransmitter, as evidenced by the glycine Hill coefficient being greater than one (Vafa et al. 1999; De Saint Jan et al. 2001) . Perhaps allosteric modulators of wild-type Gly-Rs act by increasing the frequency of channel opening events when only one or two neurotransmitter molecules are bound to the pentameric receptor (i.e. the receptor is Ôpartially activatedÕ in some manner). This is analogous to the hypothesis that benzodiazepines only enhance the function of GABA A receptors that have bound one but not two molecules of GABA (Rogers et al. 1994) . The D97R mutation may alter the a1 Gly-R such that it is already partially activated in the absence of glycine. This would explain the constitutive activity, the low Hill coefficient (the cooperativity of multiple neurotransmitter molecules binding is gone) and the direct activation of resting channels by EtOH and anesthetics. This hypothesis is also supported by the previously described explanations of the changes in conformational state equilibria in the D97R a1 Gly-R. Another explanation was put forth by Thompson et al. (1999) , who explained loss of benzodiazepine modulation in constitutively active GABA A receptors mutated in the pore (TM2) by suggesting that, because the mutation has already decreased the agonist EC 50 , a further decrease was impossible and modulation was therefore reduced. Likewise, the D97R mutation might stabilize the open channel state in a similar manner as allosteric modulators stabilize open states evoked by glycine in wildtype receptors. This would preclude positive allosteric modulation of the mutated Gly-Rs since this component of open channel stability has already been enhanced.
In summary, Gly-Rs that possess the D97R point mutation demonstrate constitutive activity in the absence of neurotransmitter. Pharmacologically relevant concentrations of EtOH and volatile anesthetics have direct activating effects on D97R receptors despite acting solely as allosteric modulators of glycine-evoked currents in wild-type receptors. Our data demonstrate that volatile anesthetics, inhalants and ethanol can affect Gly-R channel opening by a Fig. 6 Putative location of amino acid D97 in the a1 Gly-R extracellular domain. The coordinates of the acetylcholine binding protein (Brejc et al. 2001 ) (PDB ID number 1I9B) were used to make a model of the extracellular ligand-binding domain of a glycine a1 receptor. The domain is shown from the side with the most extracellular segment at the top of the figure. The five subunits that form the central ion pore were colored blue, red, green, orange and aqua. The first four of these are rendered as ribbon structures to emphasize the high beta sheet content with a single alpha helix (cylinder at top). The fifth subunit in the foreground was rendered as a backbone structure to permit visualization of the interface between the orange and aqua subunits. At this interface the amino acid residues that surround the ligandbinding pocket were rendered with space-filling surfaces that were colored to show the most positive (blue) and most negative (red) electrostatic potentials. The mutated residue D97R is shown in yellow near the edge of the ligand-binding pocket. At the bottom of each subunit one can see the Ôcys-loopÕ that is thought to be important for gating as well as the C-terminus of the ligand-binding domain that would connect to the N-terminus of the transmembrane segment. mechanism independent of their enhancement of neurotransmitter binding.
